With a view to improving quality of treatment, the country’s first government recognised diabetes treatment guideline has been launched recently.“Diabetes Care BADAS Guideline 2019” was prepared jointly by Diabetic Association of Bangladesh (BADAS) and Non-Communicable Diseases Control Programme of Directorate General of Health Services.
Additionally, to introduce digital approach in healthcare and empower physicians, an application-based treatment approach, Diabetes Journey was also launched. The app was launched jointly by BADAS and Novo Nordisk based on the new diabetes treatment guideline.
This guideline will help to model and standardise the diabetic treatment outline of the patients, and will ensure optimal control for better outcome, said Professor Dr A K Azad Khan, President of BADAS.
The diabetes journey app will empower the physicians to take effective treatment decisions based on patients’ types and needs, Dr Khan said.
BADAS aims to transform diabetes care in Bangladesh so that patients can have access to quality care and better health, said Md Sayef Uddin, General Secretary of BADAS.
As a global leader in diabetes care, Novo Nordisk has taken many initiatives to introduce digital approach in healthcare, said Anand Shetty, Managing Director of Novo Nordisk.
The diabetes journey application and the country’s first national diabetes patients’ registry are few examples of digitalisation in Bangladesh and aligned with the government’s vision for “Digital Bangladesh”, Shetty said.